Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 120.00 | 119.75 | 1.0021 | 1.0056 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 211.00 | 266.25 | 0.7925 | 0.4913 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 345.00 | 266.25 | 1.2958 | 1.7736 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 316.00 | 266.25 | 1.1869 | 1.4827 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 312.50 | 153.73 | 254.00 | 266.25 | 0.9540 | 0.8846 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 153.73 | 286.00 | 266.25 | 1.0742 | 1.1890 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 302.00 | 266.25 | 1.1343 | 1.3447 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 425.00 | 266.25 | 1.5962 | 2.6086 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 312.50 | 153.73 | 341.00 | 266.25 | 1.2808 | 1.7331 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 153.73 | 443.00 | 266.25 | 1.6638 | 2.8025 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 380.00 | 266.25 | 1.4272 | 2.1333 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 312.50 | 153.73 | 128.00 | 266.25 | 0.4808 | -0.2064 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 359.00 | 266.25 | 1.3484 | 1.9164 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 403.00 | 266.25 | 1.5136 | 2.3745 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 358.00 | 266.25 | 1.3446 | 1.9061 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 361.00 | 266.25 | 1.3559 | 1.9369 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 330.00 | 266.25 | 1.2394 | 1.6223 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 203.00 | 266.25 | 0.7624 | 0.4203 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 285.00 | 266.25 | 1.0704 | 1.1794 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 153.73 | 357.00 | 266.25 | 1.3408 | 1.8959 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 251.00 | 266.25 | 0.9427 | 0.8565 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 153.73 | 127.00 | 266.25 | 0.4770 | -0.2142 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 154.00 | 266.25 | 0.5784 | 0.0022 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 261.00 | 266.25 | 0.9803 | 0.9504 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 312.50 | 153.73 | 288.00 | 266.25 | 1.0817 | 1.2083 |